Gabriel S. Morris - 11 Jun 2024 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
CFO, Director
Signature
/s/ Gabriel Morris
Issuer symbol
IMMX
Transactions as of
11 Jun 2024
Net transactions value
$0
Form type
4
Filing time
21 Jun 2024, 17:45:10 UTC
Previous filing
10 Jun 2024
Next filing
20 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IMMX Common Stock 285,834 11 Jun 2024 Direct
holding IMMX Common Stock 270,844 11 Jun 2024 See footnote F1
holding IMMX Common Stock 24,141 11 Jun 2024 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Stock Option (Right to Buy) Award $0 +340,000 $0.000000 340,000 11 Jun 2024 Common Stock 340,000 $2.04 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein.
F2 Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC ("Alwaysraise Ventures"), the general partner of Alwaysraise Ventures I, LP. ("AVILP") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein.
F3 The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.